Investor Presentaiton
Robust IP driving the Discovery program
Clarity's proprietary SAR Technology platform can be used in conjunction with any number of targeting
ligands to create new products and new IP
CLARITY
PHARMACEUTICALS
Broad Patent Portfolio
Discovery Engine
Platform Protection
Granted and new chelator patents used in further developing
lead and back-up products
Product Protection
"
"
Maintenance of pending applications for potential continuation
or divisional filings (on existing important patents)
New patents filed on lead and back-up compounds
Pipeline Protection
New chelator patents used in future discovery products
New patents filed on novel treatment regimes for
radiopharmaceutical and imaging applications
Manufacturing and process protection
"
"
Manufacturing and formulation patents
New patents filed on manufacturing processes
CLARITY
2014 M
Select high value cancer targets
Generate and radiolabel compounds
(peptides and/or antibodies)
64Cu imaging in tumour models
眼眼
67 Cu efficacy studies in tumour models
SAR Technology platform
High value clinical candidates:
SARTATE™M, SAR-bisPSMA,
SAR-Bombesin, etc.
29View entire presentation